These medications are expensive due to high research costs, complex manufacturing processes, patent protection, and rising demand with limited supply
That's why we recommend continuing the plan as directed by your provider for better long-term results
Compliance Disclaimer This product is sold strictly for laboratory research and analytical purposes only
GLP-1 Case Study Name: Richard J., a 58-year-old male Medical History: Type 2 Diabetes Mellitus (diagnosed 7 years ago) Obesity (BMI 35 kg/m) Hypertension (well-controlled on an ACE inhibitor) Mild diabetic retinopathy Current Medications: Metformin 1000 mg twice daily, glimepiride 2 mg once daily, and lisinopril 20 mg once daily Clinical Presentation Richard presents a routine follow-up
Low cortisol level (e.g., 3 microunits/ml (21 pM) in the context of hypoglycemia suggests pathologically excessive insulin levels, with the following differential diagnosis: Exogenous insulin (unfortunately, not all are detected by the assay for example, glargine may be missed)
Cholesterol: 84mg
